Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium/salmeterol versus tiotropium, salmeterol, and intensified combination therapy in COPD
2007-005134-36Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium and salmeterol in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Trough FEV1, FEV1 AUC0-8h and 3 more. Started Dec 2007; status: terminated.
02
Drugs
tiotropiumsalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-005134-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005134-36.